Clinquest - Your Partner From Bench to Market

Pre-Clinical R&D Planning

Our Preclinical R&D Planning Practice helps our clients develop successful research strategies that bring their products into clinical trials. With broad expertise in experimental science, our Preclinical R&D Planning professionals provide services that cover all aspects of the preclinical phase of development, from the initial scientific evaluation through planning of the product manufacturing.

The Preclinical R&D Planning Practice provides our clients with strategies for:

Technology assessment and evaluation. We have in-house expertise in experimental science and can review and evaluate scientific results, and can also help our clients develop a research strategy. In addition, we can assist our client in evaluating competing technologies and in developing a strategy to achieve a technical competitive advantage.
Assay design, to detect active compounds and to measure biological activity.
Preclinical animal models. We can help design studies and interpret the results of in vivo testing. Our team has experience with a variety of animal models and recommends models that are best suited to our clients' drug-testing needs.
Toxicology, for the design of animal safety testing programs that support clinical testing of a product in man. We also arrange for toxicology studies and the preparation of documentation for submissions to regulatory agencies.
Drug optimization design, with particular expertise in the design of protein drugs to regulate biological half-life and potential immunogenicity. We can also establish criteria for product characterization, purification and formulation.
Strategies for drug manufacturing, which include determining the best method for manufacturing the product, evaluating potential manufacturing facilities and formal auditing of those potential facilities.




		Pre-Clinical R&D Planning Our Preclinical R&D Planning Practice helps our clients develop successful research strategies that bring their products into clinical trials. With broad expertise in experimental science, our Preclinical R&D Planning professionals provide services that cover all aspects of the preclinical phase of development, from the initial scientific evaluation through planning of the product manufacturing. The Preclinical R&D Planning Practice provides our clients with strategies for: Technology assessment and evaluation. We have in-house expertise in experimental science and can review and evaluate scientific results, and can also help our clients develop a research strategy. In addition, we can assist our client in evaluating competing technologies and in developing a strategy to achieve a technical competitive advantage. Assay design, to detect active compounds and to measure biological activity. Preclinical animal models. We can help design studies and interpret the results of in vivo testing. Our team has experience with a variety of animal models and recommends models that are best suited to our clients' drug-testing needs. Toxicology, for the design of animal safety testing programs that support clinical testing of a product in man. We also arrange for toxicology studies and the preparation of documentation for submissions to regulatory agencies. Drug optimization design, with particular expertise in the design of protein drugs to regulate biological half-life and potential immunogenicity. We can also establish criteria for product characterization, purification and formulation. Strategies for drug manufacturing, which include determining the best method for manufacturing the product, evaluating potential manufacturing facilities and formal auditing of those potential facilities.